Skip to main content
. 2020 Oct 9;12(10):2904. doi: 10.3390/cancers12102904

Table 3.

Comparison of sensitivity and specificity of conventional modalities and metabolomics profiling for early-stage and locally advanced gastric cancer.

Variable Metabolomics Serum Markers
All Stages Stage I + II Stage I (IA + IB) Stage IA CEA CA 19-9 CA 72-4
Sensitivity (%) 93.9 90.9 97.0 97.0 1.9 3.9 7.8
Specificity (%) 94.1 92.3 95.7 94.7 99.0 99.0 97.0